The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Goldman Steven M. since 2013.
The trader's CIK number is 1568216.
At the time of the last reporting, Goldman Steven M. was the Director of Dova Pharmaceuticals Inc.. (stock ticker symbol DOVA).
Also see all insider trading activities at Dova Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CNOB | 3,500 | $156,831 | 0 | $0 | 0 | $0 |
| 2013 | CNOB | 7,500 | $217,425 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | DOVA | 0 | $0 | 0 | $0 | 11,751 | $89,586 |
| 2018 | DOVA | 20,000 | $547,250 | 0 | $0 | 12,832 | $93,930 |
| 2017 | DOVA | 92,169 | $1,752,751 | 0 | $0 | 0 | $0 |
1. Connectone Bancorp, Inc. (CNOB)
2. Dova Pharmaceuticals Inc. (DOVA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-02-04 | CNOB | Buy | 2,151 | 44.43 | 95,568 |
| 2014-02-05 | CNOB | Buy | 349 | 44.45 | 15,513 |
| 2014-01-31 | CNOB | Buy | 1,000 | 45.75 | 45,750 |
| 2013-05-03 | CNOB | Buy | 5,500 | 29.35 | 161,425 |
| 2013-02-12 | CNOB | Buy | 2,000 | 28.00 | 56,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-26 | DOVA | Option Ex | 1,750 | 8.34 | 14,595 |
| 2019-06-20 | DOVA | Option Ex | 1,750 | 8.34 | 14,595 |
| 2019-01-02 | DOVA | Option Ex | 4,583 | 7.32 | 33,547 |
| 2019-05-13 | DOVA | Option Ex | 3,668 | 7.32 | 26,849 |
| 2018-08-13 | DOVA | Option Ex | 1,832 | 7.32 | 13,410 |
| 2018-06-21 | DOVA | Buy | 5,000 | 30.22 | 151,100 |
| 2018-06-06 | DOVA | Option Ex | 11,000 | 7.32 | 80,520 |
| 2018-06-05 | DOVA | Buy | 15,000 | 26.41 | 396,150 |
| 2017-08-15 | DOVA | Buy | 20,169 | 22.20 | 447,751 |
| 2017-07-05 | DOVA | Buy | 72,000 | 18.12 | 1,305,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldman Steven M. (Director of Dova Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.